Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells ...

A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer vaccine research are converging into a new era of more precise, personalized, ...

How can cannabidiol (CBD) combat cancer tumors? This is what a recent study published in Phytomedicine hopes to address as a ...

A University of Missouri scientist develops a cancer “flashlight” that helps identify which patients are most likely to ...

Agentic AI is moving beyond automation to actively manage clinical complexity, streamline patient journeys and expand access ...

January 12, 2026. Infinitusbio.AI, a U.S.-based Pharmatech company and creator of the proprietary Simulative AI Digital Cell Clone platform, and Oncovita, a Paris-based biotechnology company spun out ...

The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry. Deep Intelligent Pharma (DIP), a global leader in AI-driven drug R&D platforms, ...

To determine who could benefit from targeted cancer treatments, a researcher at the University of Missouri is putting tumors ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread.

Meta said the acquisition was aimed at boosting automation across consumer and business products. Manus will continue operating its subscription service after the acquisition, with no deal terms ...

Please provide your email address to receive an email when new articles are posted on . A novel AI multimodal model outperformed Oncotype DX in overall distant recurrence rate at 15 years. Additional ...